title: Long-term outcome of single pediatric donor kidney transplants between African-American and non-African-American adults.
abstract: BACKGROUND
  African-American (AA) ethnicity has been considered a risk factor for graft loss after kidney transplant. The long-term graft survival of single pediatric donor kidney transplants in AA adults has not been reported.
  
  
  METHODS
  We retrospectively compared the outcome of 43 AA and 32 non-African-American (NAA) adults transplanted with single pediatric kidneys from donors aged 10 years or less in our center. A combination of tacrolimus, mycophenolic acid and steroid was utilized as the maintenance therapy.
  
  
  RESULTS
  Similar immunosuppressive dose and targeted level were achieved between the AA and the NAA groups. Median body weight (BW) of donors was 20 kg (8 - 36) in the AA group and 19 kg (8.5 - 35) in NAA group. There was no statistically significant difference in the incidence of rejection between the AA and NAA groups (26 vs. 16%, p = 0.45). The surgical complications, delayed graft function, and development of proteinuria and focal and segmental glomerulosclerosis (FSGS) were similar in both groups. The patient and graft survivals in the AA group were slightly higher compared to the NAA group. The death-censored analysis demonstrated no difference in graft survival between the AA and NAA groups (p = 0.90): 86 vs. 82% at 1 year, 70 vs. 71% at 3 years, and 62 vs. 64% at 5 years.
  
  
  CONCLUSIONS
  Single pediatric donor kidney transplant in AA adults can be achieved with acceptable complications and equivalent long-term outcomes as in NAA adults in the era of potent immunosuppressive regimen.
authors.affiliation: Departments of Surgery, School of Medicine, Tulane University, New Orleans, LA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Paramesh
authors.forename: R
authors.initials: R
authors.lastname: Zhang
authors.forename: C L
authors.initials: CL
authors.lastname: Yau
authors.forename: S
authors.initials: S
authors.lastname: Balamuthusamy
authors.forename: R
authors.initials: R
authors.lastname: Shenava
authors.forename: M
authors.initials: M
authors.lastname: Killackey
authors.forename: B
authors.initials: B
authors.lastname: Alper
authors.forename: E
authors.initials: E
authors.lastname: Simon
authors.forename: D
authors.initials: D
authors.lastname: Slakey
authors.forename: S
authors.initials: S
authors.lastname: Florman
mesh_terms: D000328:Adult; D001741:Black or African American / Q000706:statistics & numerical data*; D016009:Chi-Square Distribution; D002648:Child; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000208:ethnology; D006630:Hispanic or Latino / Q000706:statistics & numerical data; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007677:Kidney Function Tests; D016030:Kidney Transplantation; D008145:Louisiana / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome; D044465:White People / Q000706:statistics & numerical data
chemical_list: D007166:Immunosuppressive Agents